ZBNA
ADMA icon

Zions Bancorporation, National Association’s ADMA Biologics ADMA Stock Holding History

Zions Bancorporation, National Association’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$398K Sell
44,147
-24,863
-36% -$392K 0.03% 276
2025
Q4 		$1.26M Sell
69,010
-4,852
-7% -$81.8K 0.06% 212
2025
Q3 		$1.08M Buy
73,862
+20,045
+37% +$344K 0.05% 215
2025
Q2 		$980K Buy
+53,817
New +$1.1M 0.05% 223

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Zions Bancorporation, National Association's ADMA Position: Q1 2026 in Review

Zions Bancorporation, National Association reduced its ADMA Biologics (ADMA) stake by 36% in Q1 2026, selling an estimated $392K and leaving 44,147 shares worth $398K. The position accounts for 0.03% of the portfolio, ranked #276.

Zions Bancorporation, National Association first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.26M in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Zions Bancorporation, National Association held 44,147 shares of ADMA Biologics worth $398K as of Q1 2026.
  • Zions Bancorporation, National Association sold 24,863 ADMA Biologics shares in Q1 2026, an estimated $392K.
  • ADMA Biologics made up 0.03% of Zions Bancorporation, National Association's portfolio in Q1 2026, its #276 holding.
  • Zions Bancorporation, National Association first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • Zions Bancorporation, National Association's ADMA Biologics position peaked at $1.26M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.